<DOC>
	<DOC>NCT01038739</DOC>
	<brief_summary>The purpose of the study is to determine which dose of mesalazine granules compared to placebo is more effective in the prevention of recurrence of disease.</brief_summary>
	<brief_title>Two Doses Mesalazine Granules Versus Placebo for the Prevention of Recurrence of Diverticulitis</brief_title>
	<detailed_description>The primary purpose of the study is to demonstrate the superiority of mesalazine granules compared to placebo in terms of the two primary efficacy variables 'proportion of recurrence-free patients within 48 weeks' and 'proportion of recurrence-free patients within 96 weeks'.</detailed_description>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Diverticulitis</mesh_term>
	<mesh_term>Mesalamine</mesh_term>
	<criteria>Diagnosis of leftsided uncomplicated diverticular disease confirmed by computed tomography Presence of at least one diverticulum of the left colon Most recent attack of leftsided uncomplicated diverticulitis responding to antibiotics and/or dietary modification within the last 6 months Creactive protein (CRP) &gt; upper limit of normal (ULN) or leucocytosis at the start of the most recent attack Complicated diverticular disease Rightsided diverticulitis Previous colonic surgery Presence of symptomatic organic disease of the gastrointestinal tract Active colorectal cancer or a history of colorectal cancer Hemorrhagic diathesis Active peptic ulcer disease, local intestinal infection Asthma if careful medical monitoring is not ensured Abnormal hepatic function or liver cirrhosis Abnormal renal function</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>